Pidilite Industries is India’s largest adhesives and construction chemicals company, earning from consumer and bazaar brands (Fevicol, Dr. Fixit, Roff) and a B2B business selling pigments, industrial adhesives, and construction chemicals. The economic engine is the consumer franchise: Fevicol is the laminated adhesive leader, Dr. Fixit is the strongest retail waterproofing brand, and Roff is gaining share in tile adhesives, a category where the top four to five players control 80-90% of the market and penetration is still only 25-30%. Money is made at unusually high margins for a manufacturer: Q1 FY27 gross margin was 52.5%, standalone EBITDA margin reached 26.4%, and management has held a 20-24% EBITDA corridor through raw material inflation of 40-50% at replacement cost. FY26 consolidated revenue was INR 14,553 crore, up 11.1%, with EBITDA margin expanding 120 bps year on year. That margin level, sustained while passing through multiple price increases, is the first evidence of pricing power rather than commodity conversion.
Why these economics persist is visible in the competitive responses and the distribution ecosystem. When Pidilite raises prices, competitors follow almost exactly, which shows pricing leadership and a willingness to let smaller players depend on its moves. The barriers are not patents alone: a wide plant network lowers total delivered cost, trained applicators and site supervision make Dr. Fixit a specified system for waterproofing rather than a can on a shelf, and the professional solutions group works with architects and structural consultants to lock projects before they start. Tile adhesive competition from cement and paint manufacturers is rising, but Pidilite is growing at 1.5-2x the category and claims to be the fastest among all players, helped by consistent quality and supply security in a period when unorganized players cannot absorb 40-50% replacement-cost inflation. This is a genuine moat, with the qualification being that it is a consumer brand moat plus an installation ecosystem moat, not a basic chemistry moat.
The inflection has already begun in FY27. Q1 FY27 standalone revenue rose 22.2% to INR 4,237 crore with underlying volume growth of 11.3%, led by consumer and bazaar UVG of 12.2%; B2B exports fell 8.4% because of geopolitical disruption, masking otherwise strong domestic momentum. Over the next 18-24 months, the delta will come from four dated movements: the premium white glue plant in West India commissioned in Q1 FY27 and ramping through FY28; Nio Pro tile adhesive expanding from one plant to four plants, making the premium product available nationally; paints business moving from its current five southern states plus West Bengal and Bihar toward full-scale expansion as the small-town model is refined; and exports recovering as tariff resolution normalises trade, with the stated aim of bringing overall B2B back to mid-teens growth. By the latter half of FY28, capacity should be less of a constraint in tile adhesives and core Fevicol, while growth categories such as Dr. Fixit waterproofing and Roff projects should be compounding at the 2-4x real GDP rate they have been targeting. The shape of the business in two years is therefore higher volume at similar or slightly higher margins, not a one-time margin jump.
Management walk-talk has been consistent across four quarters. The 20-24% EBITDA margin corridor was set before the raw material shock and has been reaffirmed; FY26 delivered a 120 bps consolidated margin expansion, and Q1 FY27 consolidated EBITDA margin improved another 120 bps year on year. The 26.4% standalone Q1 margin includes a one-time benefit from lower-cost inventory that management explicitly said will unwind in Q2, so the honest read is that the corridor remains intact, not that the trajectory is permanently above it. On volume, the company promised systematic double-digit underlying volume growth and delivered 11.1% for FY26 versus 9.3% in FY25, with Q1 FY27 at 11.3%. Price increases have been calibrated, not panic-driven: Fevicol took 12-15% in April and May 2026, and the company said it will rebate if raw material prices fall. Capital allocation is disciplined: capex of INR 570 crore in FY26 against INR 430 crore in FY25, within a 3-5% of revenue band, and a dividend payout ratio around 70% including a special dividend. No major commitment has been missed; the recurring risk is external, not managerial.
Earnings visibility comes from volume compounding and operating leverage. FY26 consolidated PAT grew 17.9%, Q1 FY27 standalone PAT grew 27.7% and consolidated PAT grew 30.3%, with total costs below gross margin growing only 14.5% against 22.2% revenue growth. If underlying volume growth remains at 11-12% and the 20-24% EBITDA corridor holds, revenue should grow mid-teens to low-20s over the next two years, and earnings should grow faster than revenue because fixed costs and the plant network are already being paid for. The main falsifier is raw material inflation and demand elasticity: VAM spot reached about $1,800 per tonne versus $840 in Q4 FY26, and cumulative price hikes across categories could compress volume in FY27. The tension between 52.5% gross margin (down 90 bps YoY) and 26.4% EBITDA margin is operational, not structural; it reflects timing of inventory costs and cost control. If double-digit UVG breaks or the corridor slips below 20% on a sustained basis, the compounder story is damaged; otherwise, the 18-24 month outcome is a larger, more geographically diverse Pidilite with stronger export contribution and a broader tile adhesive and waterproofing franchise.
companyname: Pidilite Industries Limited ticker: PIDILITIND sector: Adhesives, Sealants, Construction Chemicals and Art & Craft Materials Pidilite Industries Limited makes adhesives, sealants, construction chemicals, and art & craft materials. Incorporated in 1969, it operates 33 plants and 9 offices in India plus 5 offices internationally, selling to 74 countries. As of 31st March 2026, it had 8,835 permanent employees. In FY2025-26, standalone net sales were INR 13,436.50 crores, up 11.8%, an...
Read the full report →capex, margin expansion, geographic expansion
FY27 UVG guided at 100-odd bps expansion driven by planning
Guidance upgradedconsistent
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Pidilite Industries Limited and 4,900+ companies.
5-day free pass. No card required.